Trade

Phaarmasia share price

Extreme risk
  • 65%Low risk
  • 65%Moderate risk
  • 65%Balanced risk
  • 65%High risk
  • 65%Extreme risk
  • 89.35(-0.43%)
    May 15, 2026 15:26:20 PM IST
    • NSE
    • BSE
  • Vol : 0.06 K (NSE + BSE)
    Last 20 day avg : 0.44 K

Phaarmasia is trading -0.43% lower at Rs 89.35 as compared to its last closing price. Phaarmasia has been trading in the price range of 89.74 & 89.35. Phaarmasia has given -20.40% in this year & -5.54% in the last 5 days. Phaarmasia has TTM P/E ratio 4.33 as compared to the sector P/E of 24.31.The company posted a net profit of 16.27 Crores in its last quarter.Listed peers of Phaarmasia include Divi's Laboratories (-2.41%), Sun Pharmaceutical Industries (0.90%), Torrent Pharmaceuticals (-0.52%).The Mutual Fund holding in Phaarmasia was at -% in . The MF holding has - from the last quarter. The FII holding in Phaarmasia was at -% in . The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on May 15, 2026, 09:02 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    2.22
    High volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.00
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
89.35
Highest
89.74
52 week range
Lowest
26.00
Highest
131.75
Phaarmasia Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Divi's Laboratories
Bullish
6,755.00-2.411,78,679.9980.3911.780.450.01
Sun Pharmaceutical Industries
Bullish
1,879.900.904,51,076.6738.516.130.890.50
Torrent Pharmaceuticals
Bullish
4,386.00-0.521,48,148.9276.9419.540.8017.62
Cipla
Moderately Bullish
1,431.55-0.491,16,013.1019.823.351.010.81
Dr Reddy's Laboratories
Bullish
1,336.952.621,11,584.2418.693.150.632.34
Phaarmasia Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-02-06Quarterly Results
2025-11-14Quarterly Results
2025-08-11Quarterly Results
2025-05-28Audited Results
2025-02-14Quarterly Results
About the company Phaarmasia
  • IndustryBiotechnology & Drugs
  • ISININE486I01016
  • BSE Code523620
  • NSE Code
Phaarmasia Limited is an India-based company, which is primarily engaged in the manufacturing and sale of oral contraceptive pills (OCPs). The Company manufactures and markets oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for the Ministry of Health & Family Welfare and for exports. Its product categories include Hormone Products and Herbal Products. Its hormone products include Estradiol Valerate Tablets; Medroxyprogesterone Acetate Tablets; Cabergoline Tablets; Clomiphene Citrate Tablets; Levonorgestrel Tablet; Fluoxymesterone tablets; Liothyronine Sodium tablets; Oxandrolone tablets and others. Its herbal products include Smyle Herbal Toothpaste; Smyle Cough & Sore Throat Reliver and Smyle Mouth Ulcer Gel. Its injectables include Testosterone Cypionate Injection; Methenolone Enanthate Injection; Drostanolone, Testosterone and Trenbolone Inj, and Stanozolol Cypionate Inj.
  • Management Info
  • Eswara Rao NagineniChief Financial Officer
  • Urvashi BhatiaChief Compliance Officer, Company Secretary
  • Maneesh SapteManaging Director
  • Yallapragada Bhaskara RaoWhole-Time Director
Phaarmasia Share Price FAQs

Phaarmasia is trading at 89.35 as on Fri May 15 2026 09:56:20. This is -0.43% lower as compared to its previous closing price of 89.74.

The market capitalization of Phaarmasia is 55.44 Cr as on Fri May 15 2026 09:56:20.

The 52 wk high for Phaarmasia is 131.75 whereas the 52 wk low is 26.00

Phaarmasia can be analyzed on the following key metrics -

  • TTM P/E: 4.33
  • Sector P/E: 24.31
  • Dividend Yield: 0.00%
  • D/E ratio: -

Phaarmasia reported a net profit of -1.59 Cr in 2025.